ARCHIVES

FDA To Expand Disclosure For Advisory Committee Members

This article is from The Cancer Letter archive.

Vol. 36 No. 15 | April 23, 2010

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Waxman urges drug companies to list clinical trials on NIH Web site.

June 18, 2004

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

Fitness Reduces Risk of Death From Lung, Colorectal, Prostate Cancer in Middle-Aged Men

May 31, 2013

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Human Genome Project publishes its final product.

October 22, 2004